LFA-1 expression on CD4+CD45RO+ peripheral blood T-lymphocytes in RR MS: Effects induced by rIFNβ-1a

Journal of the Neurological Sciences

Volumn 186, Issue 1-2, 2001, Pages 65-73

  Avolio, Carlo ^a,b   Ruggieri, Maddalena ^b   Cafforio, Paola ^b   Giuliani, Fabrizio ^b   Silvestris, Francesco ^b   Dammacco, Franco ^b   Livrea, Paolo ^b   Trojano, Maria ^b  

^a UNIVERSITY OF FOGGIA   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

CD4+CD45RO+; Interferon 1a; LFA 1; Multiple sclerosis; Peripheral blood T lymphocytes; Soluble ICAM 1

Indexed keywords

BETA1A INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; METHYLPREDNISOLONE; RECOMBINANT INTERFERON;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; MEMORY CELL; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ADULT; ANTIGENS, CD45; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC MEMORY; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON-BETA; LONGITUDINAL STUDIES; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; SOLUBILITY;

EID: 0035331841     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(01)00506-8     Document Type: Article

References (49)

1. Demyelinating diseases
2. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm
3. Endothelial-leukocyte adhesion molecules
4. Leukocyte-endothelial adhesion molecules
5. The effects of Interferon-β on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis
6. Intramuscular Interferon β-1a for disease progression in relapsing multiple sclerosis
7. Magnetic resonance imaging results of the PRISMS trial: a randomized, double blind, placebo-controlled study of Interferon-β1a in relapsing-remitting multiple sclerosis
8. ICAM-1 expression and fluid phase endocytosis of cultured brain microvascular endothelial cells following exposure to Interferon β-1a and TNFα
9. Effects of r-IFN-beta-1b on serum circulating ICAM-1 in relapsing-remitting multiple sclerosis and on the membrane-bound ICAM-1 expression on brain microvascular endothelial cells
10. Immunoregulatory effects of interferon-β and interacting cytokines on human vascular endothelial cells. Implications for multiple sclerosis and other autoimmune diseases
11. VLA-4 expression on peripheral blood lymphocytes is downregulated after treatment of multiple sclerosis with interferon beta
12. Microglial production of TNF-alpha is induced by activated T lymphocytes. Involvement of VLA-4 and inhibition by interferon beta-1b
13. VLA-4/CD49d downregulated on primed T lymphocytes during interferon-b therapy in multiple sclerosis
14. Interferon-β downregulates expression of VLA-4 antigen and antagonized interferon-γ-induced expression of HLA-DQ on human peripheral blood monocytes
15. Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with Interferon β-1b
16. Changes of serum ICAM-1 and MMP-9 induced by rIFNβ-1b treatment in relapsing-remitting MS
17. Brain microvascular endothelial cells and leukocytes derived from patients with multiple sclerosis exhibit increased adhesion capacity
18. Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis
19. Distribution of immunoglobulin superfamily members ICAM-1, -2, -3 and the β2 integrin LFA-1 in multiple sclerosis lesions
20. Differential expression of the LFA-1 molecule on the human peripheral blood mononuclear cell subpopulations
21. The relation between T-cell expression of LFA-1 and immunological memory
22. Effects of β-IFN-1b treatment in MS patients on adhesion between PBMNCs, HUVECs and MS-HBECs: an in vivo and in vitro study
23. 1β treatment in ten patients with multiple sclerosis: a 1-year follow-up
24. Interferon-β inhibits activated leukocyte migration through human brain microvascular endothelial cell monolayer
25. The preferential accumulation of helper-inducer T lymphocytes in inflammatory lesions: evidence for regulation by selective endothelial and homotipic adhesion
26. Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CD29w, and Pgp-1) and have enhance IFN-gamma production
27. T cell memory
28. bright T cell subsets and their relationship to memory and naive T cells
29. + T-cells
30. New diagnostic criteria for multiple sclerosis: guidelines for research protocol
31. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)
32. A comparative study of the relative bioavailability of different interferon beta preparations
33. Cerebral endothelial cells are a major source for intercellular adhesion molecule-1 in the human central nervous system
34. A form of circulating ICAM-1 in human serum
35. Cleavage of membrane-associated ICAM-1 from astrocytes: involvement of a metalloprotease
36. Analysis of the production of soluble ICAM-1 molecules by human cells
37. A distinct mRNA encoding a soluble form of ICAM-1 molecule expressed in human tissues
38. Interferon β decreases T cell activation and interferon γ production in multiple sclerosis
39. Interferon beta augments suppressor cell function in multiple sclerosis
40. Interferon-beta interferes with the proliferation but not with the cytokine secretion of myelin basic protein-specific, T-helper type 1 lymphocytes
41. Interferon response heterogeneity: activation of a proinflammatory response by interferon alpha and beta. A possible basis for diverse responses to interferon beta in MS
42. How LFA-1 binds to different ligands
43. Factors controlling T-cell migration across rat cerebral endothelium in vitro
44. Avidity regulation of integrins: the driving force in leukocyte adhesion
45. Integrin leukocyte function-associated antigen-1-mediated cell binding can be activated by clustering of membrane rafts
46. Soluble intercellular adhesion molecule-1 in serum and cerebrospinal fluid of clinically active relapsing-remitting multiple sclerosis: correlation with Gd-DTPA magnetic resonance imaging-enhancement and cerebrospinal fluid findings
47. Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells
48. Both anti-CD11a (LFA-1) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis
49. Intrathecal administration of antibodies against LFA-1 and against ICAM-1 suppresses experimental allergic encephalomyelitis in rats